SHP1 Protein-tyrosine Phosphatase Inhibits gp91PHOXand p67PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB andNCF2 Genes
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; 1 of the 25 sources its claims cite were checked for support.
Abstract
The CYBB and NCF2 genes encode the phagocyte respiratory burst oxidase proteins, gp91PHOX and p67PHOX. Previously, we identified homologous CYBB and NCF2 cis elements that are necessary for lineage-specific transcription during late myeloid differentiation. We determined that these homologous cis elements are activated by PU.1, IRF1, interferon consensus sequence-binding protein (ICSBP), and the CREB-binding protein (CBP). Since expression of PU.1 and ICSBP is lineage-restricted, our investigations identified a mechanism of lineage-specific CYBB and NCF2 transcription. Since PU.1, IRF1, ICSBP, and CBP are expressed in undifferentiated myeloid cells, our investigations did not determine the mechanism of differentiation stage-specific CYBB and NCF2 transcription. In the current investigations, we determine that SHP1 protein-tyrosine phosphatase (SHP1-PTP) inhibits gp91PHOX and p67PHOX expression, in undifferentiated myeloid cell lines, by decreasing interaction of PU.1, IRF1, ICSBP, and CBP with the CYBB and NCF2 genes. We also determine that IRF1 and ICSBP are tyrosine-phosphorylated during interferon gamma differentiation of myeloid cell lines, and we identify IRF1 and ICSBP tyrosine residues that are necessary for CYBB and NCF2 transcription. Therefore, these investigations identify a novel mechanism by which SHP1-PTP antagonizes myeloid differentiation and determine that tyrosine phosphorylation of IRF1 and ICSPB mediates stage-specific transcriptional activation in differentiating myeloid cells.
Overview
CoChat Summary
TL;DR
SHP1 protein-tyrosine phosphatase activity in undifferentiated myeloid cells inhibits CYBB and NCF2 transcription and gp91PHOX/p67PHOX expression by reducing tyrosine phosphorylation of IRF1 and ICSBP and decreasing assembly of the PU.1/IRF1/ICSBP/CBP HAF1a complex. IFNγ differentiation lowers SHP1-PTP activity and increases IRF1/ICSBP tyrosine phosphorylation, linking a phosphatase/kinase balance to differentiation stage-specific oxidase gene transcription.
Key findings
- IFNγ treatment of U937 cells decreased SHP1-PTP activity by 46.1 ± 6.7% (n = 3, p = 0.017), while total PTP activity increased 326 ± 30% (n = 6, p < 0.01); SHP1 protein abundance modestly decreased.
- Dominant-negative CS453-SHP1 increased gp91PHOX and p67PHOX mRNA in undifferentiated U937 cells, whereas SHP1 overexpression decreased these mRNAs in IFNγ-treated cells; SHP1-PTP inhibition did not alter gp91PHOX mRNA stability (8-h half-life, p = 0.84) or the more stable p67PHOX message.
- CS453-SHP1 increased CYBB promoter reporter expression by 143 ± 12.8% (n = 3, p = 0.026) and NCF2 promoter reporter expression by 129 ± 10.4% (n = 3, p = 0.056); SHP1 overexpression decreased CYBB by 41.8 ± 6.6% (n = 3, p = 0.174) and NCF2 by 39.4 ± 5.5% (n = 3, p = 0.196). For the HAF1 reporter, CS453-SHP1 increased activity by 79.6 ± 17.7% in undifferentiated cells (n = 5, p = 0.027), and SHP1 overexpression decreased activity by 49.3 ± 13.3% in undifferentiated cells (n = 5, p = 0.026) and by 61.8 ± 19.6% in IFNγ-treated cells (n = 3, p = 0.037).
- IRF1 and ICSBP tyrosine phosphorylation increased with IFNγ differentiation and with CS453-SHP1, and SHP1 treatment decreased tyrosine phosphorylation of in vitro translated IRF1 and ICSBP. Mutating conserved Tyr109 in IRF1 or Tyr95 in ICSBP impaired HAF1 activation: Y109F IRF1 lost synergy with PU.1 + ICSBP (59.1% less reporter expression, n = 14, p < 0.0031), and Y95F ICSBP with PU.1 + IRF1 was 62.5% less than wild type (n = 16, p = 0.0003).
Methods
- Human U937 myelomonocytic and PLB985 promyelocytic cell lines were used; U937 cells were treated with or without IFNγ (200 or 1,000 units/ml) and stably transfected to overexpress SHP1, dominant-negative CS453-SHP1, IRF1, Y109F IRF1, ICSBP, or Y95F ICSBP.
- Reporter assays used CYBB promoter, NCF2 promoter, or artificial HAF1-element constructs; EMSA used CYBB/NCF2 HAF1 probes with nuclear proteins, PTP inhibitors, Yop phosphatase, or purified SHP1; immunoprecipitation/Western blotting assessed tyrosine phosphorylation; PTP assays measured SHP1 activity; Northern blots with actinomycin D assessed mRNA stability; GST pull-down assays tested protein-protein interactions with in vitro translated proteins.
- Reporter activity was measured by CAT assays normalized to β-galactosidase, with densitometry for Northern blots and reported n and p values.
Limitations
- The paper states it has not directly demonstrated that the conserved tyrosine residues in IRF1 and ICSBP are phosphorylated during IFNγ-induced U937 differentiation; identification of the phosphorylated residues is planned. It also notes that an unidentified PTP activated by SHP1-PTP could dephosphorylate IRF1 and ICSBP, so IRF1/ICSBP may not be direct SHP1 substrates.
- Evident from the text: most mechanistic experiments use the U937 cell line, overexpression systems, and in vitro binding/phosphorylation assays rather than primary myeloid cells or in vivo models; the authors also note that phosphorylation in rabbit reticulocyte lysate may differ from myeloid cells.
- Evident from the reported statistics: several reporter effects were not statistically significant, including the NCF2 promoter increase with CS453-SHP1 (p = 0.056) and the SHP1-overexpression decreases in CYBB and NCF2 promoter reporters (p = 0.174 and p = 0.196).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








![FIG. 6 Conserved tyrosine residues in IRF1 and ICSBP increase the affinity of protein-protein interactions. A, PU.1 has equivalent affinity for IRF1 and Y109F IRF1. PU.1/GST and control GST were analyzed for binding of in vitro translated, [ 35 S]methioninelabeled IRF1 or Y109F IRF1. Binding assays were also incubated with either control reticulocyte lysate, in vitro translated unlabeled ICSBP, or Y95F ICSBP, as indicated. Precipitating proteins were separated by SDS-PAGE, and co-precipitation of IRF1 or Y109F IRF1 with PU.1/GST or GST was detected by autoradiography. IRF1 and Y109F IRF1 bind PU.1/GST (but not control GST) with equal affinity, and binding affinity is not altered by ICSBP. B, PU.1 has greater affinity for ICSBP than for Y95F ICSBP. PU.1/GST and control GST were analyzed for binding of in vitro translated, [ 35 S]methionine-labeled ICSBP or Y95F ICSBP. Binding assays were incubated with either control reticulocyte lysate, in vitro translated, unlabeled IRF1, or Y109F IRF1, as indicated. Precipitating proteins were separated by SDS-PAGE, and co-precipitation of ICSBP or Y95F ICSBP with PU.1/GST or GST was detected by autoradiography. ICSBP binds PU.1/GST (but not control GST) with greater affinity than Y95F ICSBP. Binding affinity of both ICSBP and Y95F ICSBP for PU.1/GST is slightly increased by IRF1 but not Y109F IRF1. C, IRF1 has greater affinity for ICSBP than for Y95F ICSBP, and Tyr-109 mutant IRF1 has less affinity for ICSBP than does wild type IRF1. IRF1/GST, Y109F IRF1/GST, and control GST were analyzed for binding of in vitro translated, [ 35 S]methionine-labeled ICSBP or Y95F ICSBP, as indicated. Precipitating proteins were separated by SDSPAGE, and co-precipitation of ICSBP or Y95F ICSBP with IRF1/GST, Y109F IRF1/GST, or GST was detected by autoradiography. ICSBP binds IRF1/GST with greater affinity than Y95F ICSBP, and neither in vitro translated protein co-precipitates efficiently with Y109F IRF1/ GST. D, Y109F IRF1 does not participate in the HAF1 complex binding the CYBB HAF1 cis element, and Y95F ICSBP does not participate in either the HAF1 or HAF1a complex. U937 cells were transfected with a vector to overexpress epitope-tagged IRF1 ( lanes 1 and 2 ), ICSBP ( lanes 3 and 4 ), Y109F IRF1 ( lanes 5 and 6 ), or Y95F ICSBP ( lanes 7 and 8 ). Transfectants were treated with IFN 𝛄 for 48 h, and nuclear proteins were used in EMSA with the CYBB HAF1 cis element probe. Binding reactions were preincubated with either anti-' xpress ' epitope antibody ( lanes 2, 4, 6, and 8 ) or irrelevant, control antibody ( lanes 1, 3, 5, and 7 ). The HAF1 complex is indicated by the arrow and the HAF1a complex by the arrowhead. Epitope-tagged IRF1 and ICSBP are present in the HAF1 and HAF1a complexes, consistent with our previous results with endogenous proteins. However, Y109F IRF1 is only present in the HAF1 complex, and Y95F ICSBP is not present in either the HAF1 or HAF1a complex.](https://figures.cochat.ai/paper-figures/692982c2147647e39f195957277b1e30/shp1-protein-tyrosine-phosphatase-inhibits-gp91phoxand-p67phox-expression-by-figure-6.png)
Verification
Claims the paper makes
1 Valid · 0 Not valid · 15 Not checked · 112 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These genes, which encode the respiratory burst oxidase proteins gp91 PHOX and p67 PHOX , are actively transcribed in myeloid cells that have differentiated beyond the promyelocyte stage (8,9).”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > Abstract
What the sources say
- Partly supportedcites [8] Royer-Pokora, B., Kunkle, L. M., Monaco, A. P., Goff, S. C., Newburger, P. E., Baehner, R. L., Cole, F. S., Curnutte, J. T., and Orkin, S. H. (1986) Nature 322, 32-38 sourceExperimental — accuracy not yet measured
Royer-Pokora et al. (1986) support only half of the attributed content: the Tissue distribution section (p. 3) shows the 379/X-CGD (= CYBB) transcript is 'markedly induced in HL60 cells during granulocytic differentiation' and 'abundant in cultured normal human monocyte RNA', and the Expressed Xp21 sequences section (p. 2) notes DMF induction of the NADPH-oxidase system — i.e. expression in differentiated myeloid cells. Nothing in our copy concerns NCF2/p67PHOX: the paper only mentions 'a flavoprotein' as an unresolved candidate ('Whether the predicted protein is related to the flavoprotein found in phagocytes must await further biochemical characterization', Conclusions, p. 6) and defines autosomal-recessive CGD merely by complementation/family studies (p. 2). The gene symbols CYBB/NCF2, the gp91PHOX/p67PHOX protein names, and the specific 'beyond the promyelocyte stage' boundary are also absent (uninduced HL60 cells are described only as 'undifferentiated'). (LLM, conf=0.78)
- Not checked yetcites [9] Leto, T. L., Lomax, K. J., Volpp, B. D., Nunio, H., Sechler, J. M. G., Nauseef, W. M., Clark, R., Gallin, J. I., and Malech, H. L. (1990) Science 248, 727-730 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the current investigations, we demonstrate that SHP1-PTP activity decreases CYBB and NCF2 transcription, in undifferentiated myeloid cell lines.”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > Abstract
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that SHP1-PTP activity in SHP1-overexpressing transfectants is 34.5 Ϯ 2.2% greater than control transfectants (n ϭ 6, p ϭ 0.048).”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > SHP1-PTP Activity Decreases CYBB and NCF2 Transcription by the HAF1a
plainstates a causen = 6 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that CS453-SHP1 overexpression does not alter the 8-h half-life of gp91 PHOX mRNA in undifferentiated U937 cells (Fig. 2D, p ϭ 0.84).”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > SHP1-PTP Activity Decreases CYBB and NCF2 Transcription by the HAF1a
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Reporter gene expression, via the HAF1 cis element, is not significantly different for transfectants with PU.1 ϩ IRF1 than transfectants with PU.1 ϩ IRF1 ϩ Y95F ICSBP (n ϭ 12, p ϭ 0.38).”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > DISCUSSION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
83 more claims
Create a free account to see all 128 claims and to verify the 24 references still open.
- It may state two separate claims as one. 30
- Probably not a substantial claim. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ICSBP/IRF8 is a substrate for SHP1 and SHP2 protein-tyrosine phosphatases in undifferentiated myeloid cells (15,16).”
From PU.1, Interferon Regulatory Factor (IRF) 2, and the Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Cooperate to Activate NF1 Transcription in Differentiating Myeloid Cells (2007) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, interaction of ICSBP/IRF8 with the DNA-bound PU.1-IRF1 heterodimer requires phosphorylation of PU.1 Ser-148”
From PU.1, Interferon Regulatory Factor (IRF) 2, and the Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Cooperate to Activate NF1 Transcription in Differentiating Myeloid Cells (2007) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and ICSBP/IRF8 Tyr-95 (16,21).”
From PU.1, Interferon Regulatory Factor (IRF) 2, and the Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Cooperate to Activate NF1 Transcription in Differentiating Myeloid Cells (2007) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulating evidence indicates that ICSBP and PU.1 activate transcription through EICE and related elements in IFN𝛄 -stimulated macrophages, as reported for genes encoding the respiratory oxidases gp91 phox and p67 phox and interleukin-1 𝛃 (IL-1 𝛃 ) (13, 23, 30).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In previous control experiments, we demonstrated that wild type and Y95F ICSBP is equivalently overexpressed in U937 cells using this vector (15,16).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > DISCUSSION
“D, Y109F IRF1 does not participate in the HAF1 complex binding the CYBB HAF1 cis element, and Y95F ICSBP does not participate in either the HAF1 or HAF1a complex.”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > DISCUSSION
“However, Y109F IRF1 is only present in the HAF1 complex, and Y95F ICSBP is not present in either the HAF1 or HAF1a complex.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > DISCUSSION
“In contrast, Y95F ICSBP interacts with neither PU.1 nor PU.1 ϩ IRF1 in transfection or in vitro binding assays.”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > DISCUSSION
“Binding affinity of both ICSBP and Y95F ICSBP for PU.1/GST is slightly increased by IRF1 but not Y109F IRF1.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > IFN␥ Differentiation of U937 Cells Is Associated with IRF1 and ICSBP Tyrosine Phosphorylation-These experiments
“Additionally, IFN␥ treatment of U937 cells increases nuclear, tyrosine-phosphorylated IRF1 (Fig. 4C) and ICSBP (Fig. 4D).”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > DISCUSSION
“C, IFN␥ differentiation of U937 cells increases ICSBP tyrosine phosphorylation but not ICSBP protein abundance.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > DISCUSSION
“However, CS453-SHP1 overexpression induces less than a 2-fold increase in activity of reporter constructs with 470 bp of CYBB promoter or 400 bp of NCF2 5Ј flank in U937 cells, although IFN␥ differentiation increases expression of these constructs 4-and 5-fold, respectively (6).”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > SHP1-PTP Activity Decreases CYBB and NCF2 Transcription by the HAF1a
“Reporter expression from the 470-bp CYBB construct was 143 Ϯ 12.8% greater in CS453-SHP1 U937 transfectants than in control U937 transfectants (n ϭ 3, p ϭ 0.026).Similarly, overexpression of CS453-SHP1 increases reporter expression from the 400-bp NCF2 construct by 129 Ϯ 10.4%, relative to control U937 transfectants (n ϭ 3, p ϭ 0.056).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > SHP1-PTP Activity Decreases CYBB and NCF2 Transcription by the HAF1a
“We found that overexpression of CS453-SHP1 significantly increases reporter expression from the CYBB and NCF2 promoters (Fig. 3A).”
§ SHP1 Protein-tyrosine Phosphatase Inhibits gp91 PHOX and p67 PHOX Expression by Inhibiting Interaction of PU.1, IRF1, Interferon Consensus Sequence-binding Protein, and CREB-binding Protein with Homologous Cis Elements in the CYBB and NCF2 Genes* > SHP1-PTP Activity Decreases CYBB and NCF2 Transcription by the HAF1a
“Similarly, overexpression of CS453-SHP1 increases reporter expression from the 400-bp NCF2 construct by 129 Ϯ 10.4%, relative to control U937 transfectants (n ϭ 3, p ϭ 0.056).”
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Current Protocols in Molecular Biology
(2018) · Current Protocols in Molecular Biology · doi:10.1002/(issn)1934-3647 · Cited by 1,372
Takebe, Y., Seiki, M., Fujisawa, J.-I., Hoy, P., Yokota, K., Arai, K.-I., Yoshida, M., & Arai, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.466-472.1988 · Cited by 1,330
A simple phase-extraction assay for chloramphenicol acyltransferase activity
Seed, B., & Sheen, J.-Y. (1988) · Gene · doi:10.1016/0378-1119(88)90403-9 · Cited by 966
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Royer-Pokora, B., Kunkel, L. M., Monaco, A. P., Goff, S. C., Newburger, P. E., Baehner, R. L., Cole, F. S., Curnutte, J. T., & Orkin, S. H. (1986) · Nature · doi:10.1038/322032a0 · Cited by 833
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735
Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M., & Arai, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.466 · Cited by 631
Cloning of a 67-kD Neutrophil Oxidase Factor with Similarity to a Noncatalytic Region of p60 c-src
Leto, T. L., Lomax, K. J., Volpp, B. D., Nunoi, H., Sechler, J. M. G., Nauseef, W. M., Clark, R. A., Gallin, J. I., & Malech, H. L. (1990) · Science · doi:10.1126/science.1692159 · Cited by 386
Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356
Octamer binding proteins confer transcriptional activity in early mouse embryogenesis.
Schöler, H. R., Balling, R., Hatzopoulos, A. K., Suzuki, N., & Gruss, P. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08393.x · Cited by 335
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 271
CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter.
Skalnik, D. G., Strauss, E. C., & Orkin, S. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55363-1 · Cited by 259
Kozlowski, M., Mlinaric-Rascan, I., Feng, G. S., Shen, R., Pawson, T., & Siminovitch, K. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2157 · Cited by 235
Tucker, K., Lilly, M., Heck, L. J., & Rado, T. (1987) · Blood · doi:10.1182/blood.v70.2.372.372 · Cited by 227
Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1
Petrovick, M. S., Hiebert, S. W., Friedman, A. D., Hetherington, C. J., Tenen, D. G., & Zhang, D.-E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3915 · Cited by 218
Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut
Neufeld, E. J., Skalnik, D. G., Lievens, P. M.-J., & Orkin, S. H. (1992) · Nature Genetics · doi:10.1038/ng0492-50 · Cited by 216
Larrick, J. W., Fischer, D. G., Anderson, S. J., & Koren, H. S. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.1.6 · Cited by 212
Harder, K. W., Owen, P., Wong, L. K. H., Aebersold, R., Clark-Lewis, I., & Jirik, F. R. (1994) · Biochemical Journal · doi:10.1042/bj2980395 · Cited by 200
Eklund, E. A., Jalava, A., & Kakar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13957 · Cited by 176
Self-citationSrc Kinase Activity Is Regulated by the SHP-1 Protein-tyrosine Phosphatase
Somani, A.-K., Bignon, J. S., Mills, G. B., Siminovitch, K. A., & Branch, D. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21113 · Cited by 167
Sharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Larner, A. C., Schaper, F., Hauser, H., & Levi, B.-Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9785 · Cited by 162
Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma.
Newburger, P. E., Ezekowitz, R. A., Whitney, C., Wright, J., & Orkin, S. H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5215 · Cited by 140
Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression.
Levy, R., Rotrosen, D., Nagauker, O., Leto, T. L., & Malech, H. L. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.8.2595 · Cited by 131
Eklund, E. A., & Kakar, R. (1999) · PubMed · Cited by 124
Self-citationRegulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding Protein
Gabriele, L., Phung, J., Fukumoto, J., Segal, D., Wang, I.-M., Giannakakou, P., Giese, N. A., Ozato, K., & Morse, H. C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.411 · Cited by 114
Eklund, E. A., & Kakar, R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6095 · Cited by 113
Self-citationEklund, E. A., Jalava, A., & Kakar, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907915199 · Cited by 85
Self-citationDong, Q., Siminovitch, K. A., Fialkow, L., Fukushima, T., & Downey, G. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3220 · Cited by 58
Tapley, P. M., Shevde, N., Schweitzer, P. A., Gallina, M., Christianson, S. W., Lin, I. L., Stein, R. B., Shultz, L. D., Rosen, J., & Lamb, P. (1997) · PubMed · Cited by 52
Eklund, E. A., Luo, W., & Skalnik, D. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2418 · Cited by 48
Self-citationEklund, E. A., & Skalnik, D. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8267 · Cited by 44
Self-citationKenney, R. T., Malech, H. L., Epstein, N., Roberts, R., & Leto, T. (1993) · Blood · doi:10.1182/blood.v82.12.3739.3739 · Cited by 41
Eklund, E. A., & Kakar, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9344 · Cited by 18
Self-citation
Research works printed but not linked: 2
- Tapley, P., Shevde, N. K., Schweitzer, P. A., Gallina, M., Christianson, S. W., Lin, I. L., Stein, R. B., Shultz, L. D., Rosen, J., and Lamb, P. (1997) Exp. Hematol. 25, 122-131
- Chomszynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156 -159
Cited by
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
“In addition, the protein tyrosine phosphatase, SHP1, was shown to decrease the interactions of these proteins with the promoter elements, and so downregulate expression of both p67phox and Nox2 (171).”
BackgroundQuinn, M. T., & Gauss, K. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404216 · Cited by 480
Transcriptional control of granulocyte and monocyte development
Friedman, A. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210764 · Cited by 427
“SHP2 activity diminishes during myeloid differentiation, allowing increased IRF-8 activity and facilitating differentiation in cooperation with PU.1 (Kautz et al., 2001; Kakar et al., 2005).”
BackgroundThe tyrosine phosphatase Shp2 (PTPN11) in cancer
Chan, G., Kalaitzidis, D., & Neel, B. G. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9126-y · Cited by 382
“It is unclear how a shared key substrate could result in such distinct effects of Shp2 and Shp1 deficiency in myeloid cells.”
BackgroundInfluentialIFNγ signaling—Does it mean JAK–STAT?
Gough, D. J., Levy, D. E., Johnstone, R. W., & Clarke, C. J. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.08.004 · Cited by 289
Metadata
- Authors
- Kautz, B., Kakar, R., David, E., & Eklund, E. A.
- Affiliations
- Northwestern University (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Eklund, Elizabeth A.
- ORCID
- Eklund, Elizabeth A.
- Venue
- Journal of Biological Chemistry
- Published
- 2001-10
- Volume
- 276
- Issue
- 41
- Pages
- 37868-37878
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1514864149
- Semantic Scholar
- 8db56b1c986f08f04672cbeaef5edb74e315c9f7
- Cited by
- 61
- References
- 37
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2013: 1 · 2012: 3
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 6940 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 5400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- gp91phox, p67phox, CYBB, NCF2, respiratory burst oxidase, myeloid differentiation, PU.1, IRF1, CREB-binding protein, transcriptional regulation, tyrosine phosphorylation, interferon-gamma
- MeSH terms
- NADPH Oxidase 2, Base Sequence, Humans, Membrane Glycoproteins, Phosphoproteins, Phosphorylation, Protein Binding, RNA, Messenger, Transcription Factors, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Mutagenesis, Site-Directed, DNA Primers, NADPH Oxidases, U937 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.